Results 21 to 30 of about 9,125,683 (269)

The “Gum–Gut” Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances

open access: yesFrontiers in Immunology, 2021
In modern medicine, the oral cavity has often been viewed as a passive conduit to the upper airways and gastrointestinal tract; however, its connection to the rest of the body has been increasingly explored over the last 40 years.
K. Byrd, Ajay S. Gulati
semanticscholar   +1 more source

Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review

open access: yesDisease Markers, 2016
Background. Several studies in the last decades have focused on finding a precise method for the diagnosis of periodontal disease in its early stages. Aim.
Z. N. Majeed   +4 more
semanticscholar   +1 more source

Effects of a Novel Dental Gel on Plaque and Gingivitis: A Comparative Study. [PDF]

open access: yes, 2014
ObjectivesThe goal of this prospective, randomized, controlled, double-blinded study was to evaluate the effects of a novel dental gel on plaque and gingival health.
Ajdaharian, J   +5 more
core   +3 more sources

Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district.

open access: yesJournal of Indian Society of Pedodontics and Preventive Dentistry, 2007
High prevalence of dental diseases has been recorded in Rajasthan, however, not much work has been done to ascertain the prevalence of dental diseases in Udaipur district.
V. Dhar, Ashish Jain, T. Dyke, A. Kohli
semanticscholar   +1 more source

Dental plaque–induced gingival conditions

open access: yesJournal of Clinical Periodontology, 2018
OBJECTIVE This review proposes revisions to the current classification system for gingival diseases and provides a rationale for how it differs from the 1999 classification system.
S. Murakami   +3 more
semanticscholar   +2 more sources

Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases.

open access: yesOral Microbiology and Immunology, 2005
Antimicrobial peptides, like human beta-defensins, play an important role in the epithelial innate defense response. The aim of the present study was to investigate the quantitative expression of human beta-defensin-1, -2, and -3 in inflammatory gingival
H. Dommisch   +4 more
semanticscholar   +1 more source

Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.

open access: yesThe Journal of Periodontology, 2018
BACKGROUND A variety of systemic diseases and conditions can affect the course of periodontitis or have a negative impact on the periodontal attachment apparatus.
S. Jepsen   +24 more
semanticscholar   +2 more sources

Polymicrobial oral biofilm models: simplifying the complex [PDF]

open access: yes, 2019
Over the past century, numerous studies have used oral biofilm models to investigate growth kinetics, biofilm formation, structure and composition, antimicrobial susceptibility and host–pathogen interactions.
Appelbaum   +29 more
core   +3 more sources

Gingival fibroblasts resist apoptosis in response to oxidative stress in a model of periodontal diseases

open access: yesCell Death Discovery, 2015
Periodontal diseases are classified as inflammation affecting the supporting tissue of teeth, which eventually leads to tooth loss. Mild reversible gingivitis and severe irreversible periodontitis are the most common periodontal diseases.
Ran Cheng   +5 more
semanticscholar   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy